Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9128 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9128 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9114 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9045 |
High Similarity |
NPD6959 |
Discontinued |
0.891 |
High Similarity |
NPD7768 |
Phase 2 |
0.8774 |
High Similarity |
NPD7411 |
Suspended |
0.871 |
High Similarity |
NPD4380 |
Phase 2 |
0.8544 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7819 |
Suspended |
0.8533 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8533 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8523 |
High Similarity |
NPD1510 |
Phase 2 |
0.8485 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8467 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8442 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8415 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8385 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8378 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8323 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8313 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8293 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8253 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD1934 |
Approved |
0.825 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8247 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8217 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8199 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8047 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8037 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7965 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7953 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7953 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7952 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7949 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7941 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7937 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7937 |
Intermediate Similarity |
NPD920 |
Approved |
0.7935 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7922 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7908 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7907 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7907 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7882 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7879 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7871 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7867 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7861 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7818 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7812 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7812 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7812 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7806 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7799 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7758 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7756 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7746 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7736 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7714 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7714 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7657 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7643 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7637 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7611 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7562 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7545 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7532 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7532 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7515 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7484 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD919 |
Approved |
0.7453 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7442 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7434 |
Intermediate Similarity |
NPD2797 |
Approved |
0.741 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD4287 |
Approved |
0.74 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7382 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7365 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7355 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD943 |
Approved |
0.7294 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7285 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.725 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7241 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7237 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7234 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7216 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7211 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7193 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7175 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7171 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7159 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7124 |
Intermediate Similarity |
NPD1608 |
Approved |
0.712 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7108 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7104 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7102 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7089 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.707 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7018 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7011 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD1613 |
Approved |
0.699 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.699 |
Remote Similarity |
NPD7874 |
Approved |
0.6981 |
Remote Similarity |
NPD1296 |
Phase 2 |
0.6979 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6977 |
Remote Similarity |
NPD37 |
Approved |
0.6977 |
Remote Similarity |
NPD6279 |
Approved |
0.6977 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6977 |
Remote Similarity |
NPD6280 |
Approved |
0.6977 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6971 |
Remote Similarity |
NPD6234 |
Discontinued |
0.6968 |
Remote Similarity |
NPD6534 |
Approved |
0.6968 |
Remote Similarity |
NPD6535 |
Approved |
0.6968
|
Remote Similarity |
NPD4749 |
Approved |